MENINGOCOCCAL DISEASE IN THE RUSSIAN FEDERATION: A TEN-YEAR FOLLOW-UP
- Авторлар: Koroleva M.A.1, Gritsay M.I.1, Koroleva I.S.1, Melnikova A.A.2
-
Мекемелер:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- Шығарылым: Том 12, № 2 (2022)
- Беттер: 6-11
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287916
- DOI: https://doi.org/10.18565/epidem.2022.12.2.6-11
- ID: 287916
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Maria Koroleva
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: korolevamaria389@gmail.com
Cand. Med. Sci., Senior Researcher, Laboratory for Epidemiology of Meningococcal Disease and Purulent Bacterial Meningitides Moscow, Russia
Maria Gritsay
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: maria-griz@mail.ru
Postgraduate Student, Laboratory for Epidemiology of Meningococcal Disease and Purulent Bacterial Meningitides Moscow, Russia
Irina Koroleva
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: irina-korol@yandex.ru
Laboratory for Epidemiology of Meningococcal Infection and Purulent Bacterial Meningitis Moscow, Russia
Albina Melnikova
Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: melnikova_aa@gsen.ru
Cand. Med. Sci., Deputy Head, Epidemiological Surveillance Directorate Moscow, Russia
Әдебиет тізімі
- Pace D., Pollard A.J. Meningococcal disease: clinical presentation and sequelae. Vaccine 2012; 30(suppl 2): B3-9. doi: 10.1016/j.vaccine. 2011.12.062
- Jafri R.Z., Ali A., Messonnier N.E., Tevi-Benissan C., Durrheim D., Eskola J. et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr. 2013; 11: 17. doi: 10.1186/1478-7954-11-17
- Sridhar S., Greenwood B., Head C., Plotkin S.A., Shfadi M.A., Saha S. et al. Global incidence of serogroup B invasive meningococcal disease: a systematic review. The Lancet Infectious Diseases 2015; 15(11): 1334-46. doi: 10.1016/S1473-3099(15)00217-0
- Harrison L.H., Trotter C.L., Ramsay M.E. Global epidemiology of meningococcal disease. Vaccine 2009; 27(Suppl. 2): B51-63. DOI: 10.1016/j. vaccine.2009.04.063
- Borrow R., Alarcdn P., Carlos J., Caugant D.A., Christensen H., Debbag R. et al. The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Exp. Rev. Vaccines 2017; 16(4): 313- 28. doi: 10.1080/14760584.2017.1258308
- Lundbo L.F., Benfield T. Risk factors for community-acquired bacterial meningitis. Infect. Dis. (Lond.). 2017; 49(6): 433-44.
- Cohn A.C., MacNeil J.R., Clark T.A., Ortega-Sanchez I.R., Briere E.Z., Cody Meissner H. et al. Prevention and control of meningococcal disease recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2013; 62(2): 1-32.
- Jansen A., Sanders E., Van Der Ende A., Van Loon A.M., Hoes A.W., Hak E. Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity? Epidemiol. Infect. 2008; 136(11): 1448-54. DOI: 10.1017/ S0950268807000271
- Cohen A.L., McMorrow M., Walaza S., Cohen C., Tempia S., Alexander-Scott M. et al. Potential impact of co-infections and co-morbidities prevalent in Africa on influenza severity and frequency: A systematic review. PLoS ONE 2015; 10(6): e0128580. doi: 10.1371/journal. pone.0128580
- Vipond C., Care R., Feavers I.M. History of meningococcal vaccines and their serological correlates of protection. Vaccine 2012; 30(Suppl. 2): B10-7. doi: 10.1016/j.vaccine.2011.12.060
- Королева М.А., Грицай М.И., Миронов К.О., Ярыгина Е.А., Валдохина А.В., Янушевич Ю.Г. и др. Эпидемиологические проявления вспышки менингококковой инфекции, обусловленной Neisseria meningitidis серогруппы А, в Новосибирске в 2019 г. Эпидемиол. инфекц. болезни. Актуал. вопр. 2021; 11(2): 13-21. doi: 10.18565/epidem. 2021.11.2.13-21